Outcome of Committee Meeting
This is to inform you that the Allotment Committee of Directors at its meeting held today i.e. on Friday, May 26, 2017 allotted:a)3,000 (Three Thousand) equity shares of the Company of Re 1/- each, on exercise of stock options under the Sun Employee Stock Option Scheme - 2015. b)12,000 (Twelve Thousand) equity shares of the Company of Re 1/- each, to Sun Pharma ESOP Trust for further allocation to the employees on... US FDA accepts BLA application for psoriasis drug: Sun Pharma
Regulatory filing by FDA marks a significant milestone to advance for tildrakizumab: Sun Pharma Ceo Press Release
Dear Sirs, We are pleased to enclose herewith our Press Release relating to US FDA Filing Acceptance of Biologics License Application (BLA) For Tildrakizumab, which we shall be releasing after sending this letter to you. This is for your information and records. In More Pain For Drugmakers, Investors Wealth Plunges By Rs 19,000 Crore
Analysts say the fresh selloff in the pharmaceutical shares has been triggered after Sun Pharma's US-based subsidiary Taro Pharmaceuticals reported a weak set of earnings in the March quarter. Newspaper Advertisement Regarding Notice Of Postal Ballot And Remote E-Voting For NCLT Convened Meeting Of Equity Shareholders Of Sun Pharmaceutical Industries Limited
Newspaper Advertisement regarding Notice of postal ballot and remote e-voting for NCLT Convened Meeting of equity shareholders of Sun Pharmaceutical Industries Limited Drug pricing regulator clamps down on drug cocktails
Sun Pharma will check every product listed in regulator's notice to ascertain its status Newspaper Advertisement Regarding Notice Of The National Company Law Tribunal Convened Meetings Of The Sun Pharmaceutical Industries Limited
Newspaper Advertisement regarding Notice of the National Company Law Tribunal Convened Meetings of the Sun Pharmaceutical Industries Limited Sun Pharma To Announce Fourth Quarter Results On May 26, 2017
Dear Sirs, We are pleased to enclose herewith our Press Release relating to announcement of financial results for the fourth quarter ending March 31, 2017, which we shall be releasing after sending this letter to you. This is for your information and record. Thanking you, Submission Of Corrigendum To The Notice Of The National Company Law Tribunal ('NCLT') Convened Meeting Of The Sun Pharmaceutical Industries Limited
We refer to our earlier letter dated May 11, 2017 to the Stock Exchanges, submitting the Notices of the NCLT Convened Meetings of the equity shareholders and unsecured creditors of the Company dated April 26, 2017. Please note that there was an error in mentioning the day of commencement of the voting period for remote e-voting and postal ballot in the said Notice of the NCLT Convened Meeting of the equity shareholders. In the said notice, the...